JBT — Q3 2023 Form 10-Q Summary
Reporting period: Quarter and nine months ended September 30, 2023. The filing registrant is John Bean Technologies Corporation (JBT); the supplied metadata labels the company “JBT MAREL Corp.” Unless noted otherwise, financial figures below are for continuing operations and in U.S. dollars.
Business context and key results
JBT provides technology, equipment and services to food and beverage customers. On August 1, 2023, it sold AeroTech to Oshkosh Corporation, positioning JBT as a food-and-beverage-focused company. AeroTech’s results are reported as discontinued operations.
| Metric | Q3 2023 | Q3 2022 | Nine months 2023 | Nine months 2022 |
|---|---|---|---|---|
| Revenue | $403.6m | $398.8m | $1,219.8m | $1,149.1m |
| Gross margin | 35.7% | 34.0% | 34.6% | 33.4% |
| Operating income | $36.0m | $34.8m | $106.9m | $89.8m |
| Continuing-operations income | $30.5m | $25.7m | $74.6m | $71.3m |
| Adjusted EBITDA, continuing operations | $66.3m | $60.6m | $192.1m | $158.9m |
| Adjusted EBITDA margin | 16.4% | 15.2% | 15.7% | 13.8% |
Q3 revenue rose 1.2%; nine-month revenue rose 6.2%. Nine-month net income was $524.2m, including $449.6m of income from discontinued operations. Q3 net income was $467.6m, including $437.1m from discontinued operations. These totals were heavily affected by the AeroTech sale, including a reported $444.1m after-tax gain.
Cash flow, debt and liquidity
- Continuing operating cash flow was $95.6m for the first nine months, versus $87.0m in 2022. Capital expenditures were $46.2m.
- Continuing investing cash flow was $612.7m, including $793.2m net proceeds from the AeroTech sale; continuing financing cash flow was an outflow of $345.7m, including debt repayments.
- At September 30, cash was $401.7m and marketable securities were $125.0m. Long-term debt, net, was $645.8m; gross borrowings were $652.5m, including $250.0m drawn on the revolving facility and $402.5m of convertible notes.
- The company reported $1.04bn of revolver availability and stated liquidity of $1.19bn. It was in compliance with credit covenants. The filing’s stated liquidity figure does not clearly reconcile to the listed cash, securities and revolver availability.
- Stockholders’ equity was $1,373.1m, compared with $862.7m at year-end 2022, largely reflecting income from the sale.
Changes, outlook and risks
- Continuing-operations gross margin and adjusted EBITDA margin improved year over year. Management attributed margin gains to pricing, restructuring savings, sourcing initiatives and a higher recurring-revenue mix.
- Q3 organic revenue declined $8.3m, despite higher pricing and recurring-revenue volume, as non-recurring volume fell. Management described demand as mixed: Europe and Asia Pacific improved, while North America softened, particularly in poultry and meat markets. It expected healthier poultry-market dynamics to support orders in Q4 and 2024.
- No full-year revenue or earnings guidance is provided in the supplied filing text. Management expected positive cash flow for 2023 and capital expenditures of $50m–$60m, including $12m–$14m for the OmniBlu digital platform.
- The 2022/2023 restructuring plan’s expected total cost was raised to $16m–$18m, with all costs expected by year-end 2023. Expected cumulative savings were $18m–$20m; expected 2023 savings were $9m–$10m, with remaining savings in 2024.
- Management cited risks including economic and geopolitical uncertainty, higher interest rates, inflation and supply constraints, foreign exchange movements, customer demand and contract risks, cyber threats, and the possibility of failing to meet debt covenants. It reported no material change in market risks and no material legal proceedings identified during the quarter.
Important facts for investors to verify
- Separate ongoing food-and-beverage performance from AeroTech’s discontinued results and the one-time sale gain when assessing earnings and EPS.
- Check the reconciliation of reported $1.19bn liquidity against cash, marketable securities and revolver availability, and confirm the post-sale debt and tax cash uses.
- Track whether restructuring costs, projected savings and margin improvements meet management’s revised expectations.
- Assess order trends in North America versus Europe and Asia Pacific, and whether anticipated poultry demand improvement materializes.
- Review the risks and timing of the approximately $143.4m expected tax payment on the AeroTech sale and any purchase-price adjustments.